Reports - Press Releases

Date	Title	Company
16-Dec-2025	Single Injection of JointStem Demonstrates Sustained Clinical Benefits Over Five Years	ACCESS Newswire
16-Dec-2025	Medical Care Technologies (OTC Pink:MDCE) Deploys AI to Identify Historic Memorabilia Acquisitions Strengthening Long-Term Financial Stability	ACCESS Newswire
16-Dec-2025	One Year After Go-Live, NOVO Hospital Confirms the Long-Term Value of Digital Pathology with Tribun Health	ACCESS Newswire
16-Dec-2025	Join AIML's Live Shareholder Update with Chairman & CEO Paul Duffy	ACCESS Newswire
16-Dec-2025	uBriGene Launches LVV Turbo(TM) - Its Next-Generation GMP Lentiviral Vector Manufacturing Platform - and announces a Strategic Partnership with Syenex for integration of its UltraCell(TM) Technology	ACCESS Newswire
16-Dec-2025	How to Choose the Best Plastic Surgeon in Tampa, FL: Gruber Plastic Surgery Releases Patient Safety Checklist	ACCESS Newswire
16-Dec-2025	CTT Pharma's Scientists Publish Peer-Reviewed Paper in the Journal of Drug Delivery and Therapeutics	ACCESS Newswire
16-Dec-2025	Genflow Completes Dosing Phase of Canine Gene Therapy Trial	ACCESS Newswire
16-Dec-2025	President Trump Cleaning Up Biden's Marijuana Mess - MMJ Preparing to Move FDA Huntington's Cannabis Trials Forward	ACCESS Newswire
15-Dec-2025	Healthcare Payer IT in 2026: Digital Prior Authorization, Enforceable Transparency, and Outcomes-Driven Platforms Spark a New Acquisition Race	ACCESS Newswire
15-Dec-2025	New National Alliance Launches to Address Health Workforce Shortages in Underserved Communities	ACCESS Newswire
15-Dec-2025	Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million	ACCESS Newswire
15-Dec-2025	Medical Care Technologies, Inc. (OTC Pink:MDCE) Completes First AI Consumer App Targeting Deployment Across 100+ Countries and 30 Languages	ACCESS Newswire
15-Dec-2025	Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)	ACCESS Newswire
15-Dec-2025	Aytu BioPharma Announces Commercial Availability of EXXUA(TM) (gepirone) Extended-Release Tablets, the First and Only 5HT1a Agonist Indicated for the Treatment of Major Depressive Disorder in Adults	ACCESS Newswire
15-Dec-2025	IGC Pharma Positions as a Singular Beneficiary of Emerging Federal Momentum Toward Schedule III Cannabinoid Medicines	ACCESS Newswire
15-Dec-2025	EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's mNEXSPIKE (COVID-19 Vaccine, mRNA)	ACCESS Newswire
15-Dec-2025	Amphastar Announces FDA Approval for Teriparatide Injection	ACCESS Newswire
15-Dec-2025	Multi Sciences Elevates Research Access with Global Bioz Badges Roll-out	ACCESS Newswire
15-Dec-2025	Biovica Signs Client Bill Agreement with Leading U.S. NCI-Designated Cancer Center	ACCESS Newswire